AKI in Acute Dialysis Units outside ICU across Finland
|
|
|
- Hugo Harvey
- 9 years ago
- Views:
Transcription
1 AKI in Acute Dialysis Units outside ICU across Finland Mikko Haapio, MD Consulting Nephrologist Helsinki University Central Hospital Department of Nephrology
2 FINNAKI-Nephro In conjunction with the main FINNAKI Study First Finnish study to explore acute RRT outside ICUs aims: - Incidence - Characteristics of patients and therapy - Prognosis relating to - RRT modalities - Duration of RRT - Diagnoses - AKI biomarkers
3 FINNAKI-Nephro Inclusion Patients treated in nephrological units, outside ICUs - Acute renal replacement therapy started, or - Indication for acute RRT existed, but a conservative approach was chosen (e.g. high age, multiple comorbidity, etc.)
4 FINNAKI in Nephrological Units (outside ICUs) - 17 (14) centres - 11 with patient recruitment Patient recruitment
5 Centres with patient recruitment patient-% of all Helsinki University Hospital Tampere University Hospital Oulu University Hospital Jyväskylä Central Hospital Kuopio University Hospital Turku University Hospital Pori Cental Hospital Lappeenranta Central Hospital Joensuu Central Hospital Kokkola Central Hospital Vaasa Central Hospital
6 AKI Non-AKI Number of patients Helsinki University Hospital Oulu University Hospital Jyväskylä Central Hospital Tampere University Hospital Kuopio University Hospital Turku University Hospital Pori Cental Hospital Lappeenranta Central Hospital Joensuu Central Hospital Kokkola Central Hospital Vaasa Central Hospital
7 Basic characteristics All patients (n=137) Patients with AKI (n=93) Gender, males n (%) 77 (56) 52 (56) Age, males, median (IQR) 66 (49-77) 64 (49-74) Age, females, median (IQR) 66 (55-77) 68 (59-77) Plasma crea within recent year, median (IQR), µmol/l Plasma crea within recent year, mean (SEM), µmol/l 130 (88-215) 129 (89-205) 181 (14.7) 180 (17.3) Chronic kidney disease, n (%) 75 (55) 56 (60)
8 RIFLE Urine, % of AKI patients All AKI patients AKI patients on RRT 0 Risk Injury Failure
9 Comorbidities, % of AKI patients Hypertension Heart failure Atherosclerotic disease Type 2 diabetes Type 1 diabetes Connective tissue disease Kidney transplant Non-metastatic cancer COPD Chronic liver disease Transplant other than kidney
10 Infection suspected Infection diagnosed Predisposing factors, Hypovolemia % of AKI patients Rhabdomyolysis Hypotension Operation within 1wk Infection in 71%! IV contrast media Cardiogenic shock Resuscitation Acute liver failure Renal artery obstruction Urine flow obstruction Intoxication Massive blood transfusion
11 Predisposing drugs, % of AKI patients Diuretic ACEi or ARB NSAID Nephrotoxic antibiotic Colloid
12 RRT decision, all patients (n=137)
13 First RRT modality, all patients treated (n=107)
14 RRT decisions, patients with AKI (n=93)
15 First RRT modality, AKI patients treated (n=71)
16 Alive at hospital discharge or day 28 all patients (data for 129 of 137) All Males Females n %
17 Alive at hospital discharge or day 28 all AKI patients (n=93) All Males Females n %
18 Alive at hospital discharge or day 28 AKI patients with RRT (n=71) All Males Females n %
19 Alive on day 90 all patients (data for 129 of 137) All Males Females n %
20 Alive on day 90 all AKI patients (n=93) All Males Females n %
21 Alive on day 90 AKI patients with RRT (n=71) All Males Females n %
22 Dialysis dependence and outcome AKI patients with RRT (n=71)
23 Conclusions Acute renal replacement therapy unevenly given across Finland - Local resources and hospital procedures Of acute patients in Finnish Nephrological Units: - About two thirds have AKI % of AKI patients do not enter RRT - Mortality of AKI patients on RRT: - hospital 14% - 90-day 25%
24 Centres in FINNAKI-Nephro Helsinki Unversity Hospital Lohja: Terhi Martikainen, Mervi Haapala Porvoo: Karri Helin Tammisaari: Maija Heiro, Marja Stenborg, Kaj Metsärinne Meilahti: Mikko Haapio Kuopio University Hospital Arto Pulkkinen, Pauli Karhapää Oulu University Hospital Päivi Lepistö, Jutta Huhti, Minna Tamminen Tampere University Hospital Jukka Sauranen, Martti Metso Turku University Hospital Niina Koivuviita, Risto Tertti Lappeenranta Central Hospital Jari Hartman, Johanna Sinkko Kokkola Central Hospital Stefan Anderson Jyväskylä Central Hospital Marja Miettinen, Kari Vääräniemi Rovaniemi Central Hospital Tapani Salonen, Hellevi Lohi Kemi Central Hospital Pirkko Nyländen, Mari Lantto Joensuu Central Hospital Kirsti Jääskeläinen Pori Central Hospital Kaisa Laine, Maarit Vainiotalo Savonlinna Central Hospital Mika Taskinen Vaasa Central Hospital S Anna Salmela Research coordinator: Hillevi Boman
25
26 Non-critically ill patients 5-fold risk to be admitted to ICU 8-fold risk of hospital mortality (AKI = crea-increase > 26 µmol/l) Barrantes F et al. Mayo Clin Proc 2009;84.
27 Patients with acute congestive heart failure (sub)acutely progressing to dialysis-dependent renal failure survival from RRT start: 95 days (median) to 444 days (mean) Patients > 60 years with acute renal failure RRT for 40%, 26% outside ICUs, 3-year follow-up crea > 124/115 males/females mortality 59% (hospital-acquired ARF) Lindner G ym. Wien Klin Wochenschr. 2009;121. Sesso R ym. AJKD 2004;44.
28 n No renal replacement therapy Elderly - AKI 66 ± 12 yrs After hospital discharge: - All: 17,4% died - AKI: 29,8% AKI - Non-AKI: 16,1% Adjusted mortality risk increased according to worsening AKIN stage Lafrance JP, Miller DR, JASN 2010.
The FINNAKI Study -RRT in Finland
The FINNAKI Study -RRT in Finland Suvi Vaara, MD Intensive Care Units, Division of Anaesthesiology and Intensive Care Medicine Helsinki University Central Hospital Finland Overview FINNAKI what & why AKI
Overview. Aims & Methods Incidence of RRT for AKI Characteristics - RRT patients - RRT treatment Outcome Factors asssociated with outcome
RRT in Finland Suvi Vaara, MD Intensive Care Units, Division of Anaesthesiology and Intensive Care Medicine Helsinki University Central Hospital Finland Overview Aims & Methods Incidence of RRT for AKI
Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology*
Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* =Abstracts= Registry committee of Korean Society of Nephrology
Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure
Table 1 Performance Measures # Category Performance Measure 1 Behavioral Health Risk Assessment and Follow-up 1) Behavioral Screening/ Assessment within 60 days of enrollment New Enrollees who completed
James F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
Financing for starting a business
Financing for starting a business Financing from Finnvera for launching a business Are you planning to set up an enterprise? A good business idea, the readiness to work as an entrepreneur, and careful
Internationalization and higher education policy: Recent developments in Finland
Internationalization and higher education policy: Recent developments in Finland Seminar on Cooperation between Russian and Finnish Institutions of Higher Education St Petersburg 5.-7.2.2008. Rector Anneli
Nierfunctiemeting en follow-up van chronisch nierlijden
Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated
Optimal fluid therapy in 2013. Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University
Optimal fluid therapy in 2013 Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University EGDT: fluids are good & prevent AKI Lin et al, Shock 2006 EGDT and AKI Prowle et
Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE
Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.
The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
Urine NGAL in the critically ill
Urine NGAL in the critically ill preliminary results of the FINNAKI study Sara Nisula Intensive Care Units, Division of Anaesthesia and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki,
Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care
Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE...2 FLOW DIAGRAM: POST AKI MANAGEMENT
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
Finnish Experiences of the EAFRD and Programme Based Rural Development 16.4.2010 Reykjavik
Finnish Experiences of the EAFRD and Programme Based Rural Development 16.4.2010 Reykjavik Ministerial Adviser Sirpa Karjalainen MAF, Finland [email protected] www.mmm.fi/en 1 case Finland Preparation
Accommodation statistics
Transport and Tourism 2012 Accommodation statistics 2012, July Nights spent by resident tourists decreased by 4 per cent in July 2012 The number of recorded nights spent by resident tourists at Finnish
GENERAL AGREEMENT ON TARIFFS AND TRADE. GPR/Spec/69 14 August 1992. Procurement, which was circulated informally on 6 March 1992.
GENERAL AGREEMENT ON TARIFFS AND TRADE RESTRICTED GPR/Spec/69 14 August 1992 Informal Working Group on Negotiations on Government Procurement NEGOTIATIONS ON GOVERNMENT PROCUREMENT Offers Attached is a
Education in Finland
Education in Finland University of Jyväskylä founded in 1934 one of the largest universities in Finland London Berlin total income 176,9 million euros Paris 7 faculties Madrid Rome Athens over 15 700 students
Guideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
Guidelines for Reuse and Refurbishment
The Varied History of Finnish Health Care Buildings Guidelines for Reuse and Refurbishment 19.-21.11.2014 Helsinki, Finland Antti Autio, M.Sc. (Archit.) SAFA, Development Director Matti Anttila, Architect
Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
Divestment of Anttila Oy to 4K INVEST. Media conference 16 Mar. 2015 President and CEO Mikko Helander
Divestment of Anttila Oy to 4K INVEST Media conference 16 Mar. 2015 President and CEO Mikko Helander Anttila Oy s share capital has been sold to 4K INVEST The transaction includes: 23 Anttila department
Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1
Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have
MEASURING CARE QUALITY
MEASURING CARE QUALITY Region November 2015 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance
Grading of acute kidney injury (2013)
Acute kidney disease represents a spectrum of disease associated with a sudden onset of renal parenchymal injury most typically characterized by generalized failure of the kidneys to meet the excretory,
THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION. feel better knowing
THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION feel better knowing your choice will help create more memories. Methods of Kidney Donation Kidneys for transplantation are made available through deceased
Progressive Care Insurance for life A NEW TYPE OF INSURANCE
Progressive Care Insurance for life A NEW TYPE OF INSURANCE New Progressive Care from Sovereign Progressive Care is a type of insurance that is new to New Zealand. It s not a traditional all-or-nothing
Open the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke
Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis
Regional innovation hubs and their role to international cooperation
Regional innovation hubs and their role to international cooperation Brazilian delegation 22-26th August 2011 Ministerial Adviser, Dr. Pirjo Kutinlahti Outline Finnish cluster policy approach Centre of
Medicare Risk Adjustment and You. Health Plan of San Mateo Spring 2009
Medicare Risk Adjustment and You Health Plan of San Mateo Spring 2009 Background CMS reimburses health plans on a risk-adjusted basis: The sicker a member is expected to be, the more CMS pays a plan, which
Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK
Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations
Complete coverage. Unbeatable value.
Quest Travel Insurance Complete coverage. Unbeatable value. Quest with confidence, anytime, anywhere! Quest protects you when nothing else can, with: Future stability coverage: Stable now? Not sure you
Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
ESCMID Online Lecture Library. by author
Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare
Sepsis Awareness Month
Aon Kenya Insurance Brokers Ltd Aon Hewitt Healthcare Division Sepsis Awareness Month Issue 11 September 2015 In this Issue 2 Getting to understand Sepsis 3 Stages in Sepsis Advancement 4 Diagnosis & Treatment
Breaking the Code: ICD-9-CM Coding in Details
Breaking the Code: ICD-9-CM Coding in Details ICD-9-CM diagnosis codes are 3- to 5-digit codes used to describe the clinical reason for a patient s treatment. They do not describe the service performed,
THE EU ETS IN THE FINNISH CONTEXT Does the ETS support local bioenergy implementation?
THE EU ETS IN THE FINNISH CONTEXT Does the ETS support local bioenergy implementation? Pirkko Vesterinen, VTT IEA Task 38 & Task 4 Workshop, Trondheim 5-6 April 26 FUEL PRICES IN HEAT PRODUCTION Fuel chips
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting
POAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156
introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected
Kidneys. Kidney Failure4. Transplantation
Kidneys & Kidney Failure4 Transplantation This booklet helps you understand the process of transplantation. It defines the criteria for a donor and the recipient. It also clearly explains the concepts
1 Introduction. Kari I. Leväinen
1 Introduction Kari I. Leväinen Professor of Real Estate and Facilities Management, Helsinki University of Technology, Institute of Real Estate Studies, PL 1200, FIN-02015 TKK The municipal organisations
NHS outcomes framework and CCG outcomes indicators: Data availability table
NHS outcomes framework and CCG outcomes indicators: Data availability table December 2012 NHS OF objectives Preventing people from dying prematurely DOMAIN 1: preventing people from dying prematurely Potential
Population health management at Cleveland clinic
Population health management at Cleveland clinic Sankar D Navaneethan, MD, MS, MPH Using Health Information Technology to Identify and Manage CKD Populations Oct 22-23 2015 Objectives Development of an
Data, Outcomes and Population Health Management. CPPEG January 2016
Data, Outcomes and Population Health Management CPPEG January 216 NHS Outcomes Framework There are national outcome measures which the CCG is held to account on. In conjunction to monitoring these the
Cardiovascular Endpoints
The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 30
Renovascular Hypertension
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
Our Blood Service ANNUAL REPORT
Our Blood Service ANNUAL REPORT 2012 Finnish Red Cross Blood Service Part of the Finnish health care system THE FINNISH Red Cross Blood Service (FRCBS) is a financially and operationally independent unit
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
Saint Francis Kidney Transplant Program Issue Date: 6/9/15
Kidney Transplant Candidate Informed Consent Education Here are educational materials about Kidney Transplant. Please review and read these before your evaluation visit. The RN Transplant Coordinator will
Jon S. Howell, LNHA President & CEO Georgia Health Care Association November 18, 2013
Jon S. Howell, LNHA President & CEO Georgia Health Care Association November 18, 2013 GEORGIA HEALTH CARE ASSOCIATION Represents 336 skilled nursing facilities 13 SOURCE agencies 15 assisted living communities
Luovi Vocational College
Providing VET supporting individual Luovi in figures The largest special needs VET provider in Finland Spread across over 20 sites Staff around 850 About 1 500 students in initial VET (IVET) About 1 000
ACCOMODATION FOR EXCHANGE STUDENTS
*Accomodation in Finland: http://www.soa.fi/eng/index.htm ACCOMODATION FOR EXCHANGE STUDENTS Hämeenlinna Joensuu Jyväskylä Kajaani Kemi Kotka Kuopio Lahti Lappeenranta Mikkeli Pori Rauma Rovaniemi Savonlinna
Critical Illness Direct
Critical Illness Direct Specified Disease/Condition & Major Organ Transplant Plan Proprietary and Confiden/al. All products underwri7en by The Chesapeake Life Insurance Company SM Critical Illness Direct
Is a kidney transplant right for me?
Is a kidney transplant right for me? Your guide to the transplant process www.esrdncc.org Contents Introduction 3 What is a Transplant Center? 4 What is the Waiting List? 5 What Happens After the Surgery?
SUMMARY TABLE OF MEASURE CHANGES
Summary Table of Measure 1 SUMMARY TABLE OF MEASURE CHANGES Guidelines for Physician Measurement Effectiveness of Preventive Care Guidelines for Physician Effectiveness of Care Adult BMI Assessment Weight
9 th Duodecim International symposium: Enhancing Public Health through Pharmacoepidemiology and Pharmacoeconomics
9 th Duodecim International symposium: Enhancing Public Health through and Pharmacoeconomics PROGRAM 17:00-21:00 Arrival, Registration, Poster Set-up 18:00-21:00 Get-together Setting the Scene Chair: Risto
UNIVERSITY OF OULU. Department of Electrical Engineering (EE)
UNIVERSITY OF OULU Department of Electrical Engineering (EE) University of Oulu Founded in 1958 6 faculties 16 000 students 2900 employees Total funding EUR 226 million Among the largest universities in
LUMA CENTRE FINLAND: NATIONAL LUMA DAYS NATIONAL SCIENTIX DAYS THE 5 TH ISSE SYMPOSIUM
LUMA CENTRE FINLAND: NATIONAL LUMA DAYS NATIONAL SCIENTIX DAYS THE 5 TH ISSE SYMPOSIUM Prof. Maija Aksela The head of the LUMA Centre Finland [email protected] LUMA = STEM LU stands for natural
Kidney and Pancreas Transplant Evaluation Clinics and Committee: Inpatient Nephrology Transplant Consult Service
Care of Renal Transplant Patients takes place in five distinct practice settings at the University of Michigan: a) Kidney and Pancreas Pre-transplant evaluation clinics (five half-day clinics per week)
How To Pay For Critical Illness Insurance From The Ihc Group
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Insurance It s cash when you need it. You choose how to spend it. So you can focus on getting well.
Curriculum for Nephrology Fellowship
Curriculum for Nephrology Fellowship Consultation: FMLH Service Description of Rotation or Educational Experience This part of the fellowship program in Nephrology provides training and experience such
Critical Illness Supplemental Insurance
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Supplemental Insurance It s cash when you need it. You choose how to spend it. So you can focus
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n
Limited Pay Policy (L-222B) - Underwriting Guidelines
Limited Pay Policy (L-222B) - Underwriting Guidelines 1 Addiction/Abuser Drug - Past or Present Presently Recovered - AA for last 2 years 2 Aids 3 Alcoholic Presently Recovered - AA for last 2 years 4
A Detailed Data Set From the Year 2011
2012 HEDIS 2012 A Detailed Data Set From the Year 2011 Commercial Product We are pleased to present the AvMed HEDIS 2012 Report, a detailed data set designed to give employers and consumers an objective
HYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
The Global Alliance against Chronic Respiratory Diseases
The Global Alliance against Chronic Respiratory Diseases Pulmonary hypertension Dr Marc Humbert What is the burden of pulmonary hypertension? The true burden of pulmonary hypertension is currently unknown
Caring About Palliative Care An overview
Caring About Palliative Care An overview Developed by the Palliative Care Consultation Team at VH and C. Talbot, Palliative Care Consultation Team at UH Presented by: Lee Ann Craig NP, Palliative Care
Why and how to have end-of-life discussions with your patients:
Why and how to have end-of-life discussions with your patients: A guide with a suggested script and some basic questions to use The medical literature consistently shows that physicians can enhance end-of-life
University Properties of Finland University of Oulu Campus development 24.4.2013
University Properties of Finland University of Oulu Campus development 24.4.2013 Aki Havia Suomen Yliopistokiinteistöt Oy University Properties of Finland Ltd. University Properties of Finland was founded
LIMITED BENEFIT HEALTH COVERAGE FOR SPECIFIED CRITICAL ILLNESS. OUTLINE OF COVERAGE (Applicable to Policy Form CI-1.0-NC)
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P.O. Box 1365, Columbia, South Carolina 29202 1.800.325.4368 www.coloniallife.com A Stock Company LIMITED BENEFIT HEALTH COVERAGE
Kidney Disease: Key Facts and Figures. September 2010
Kidney Disease: Key Facts and Figures September 2010 ii Kidney Disease Key Facts and Figures Contents Introduction... 1 1 Kidney disease common definitions... 2 1.1 Chronic kidney disease... 2 1.2 Acute
2010 QARR QUICK REFERENCE GUIDE Adults
2010 QARR QUICK REFERENCE GUIDE Adults ADULT MEASURES (19 through 64 years) GUIDELINE HEDIS COMPLIANT CPT/ICD9 CODES DOCUMENTATION TIPS Well Care Access to Ambulatory Care Ensure a preventive or other
The new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
Service delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
11/2/2015 Domain: Care Coordination / Patient Safety
11/2/2015 Domain: Care Coordination / Patient Safety 2014 CT Commercial Medicaid Compared to 2012 all LOB Medicaid Quality Compass Benchmarks 2 3 4 5 6 7 8 9 10 Documentation of Current Medications in
Critical Illness Insurance
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Insurance It s cash when you need it. You choose how to spend it. So you can focus on getting well.
Estimated GFR Based on Creatinine and Cystatin C
Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,
Brief Research Report: Fountain House and Use of Healthcare Resources
! Brief Research Report: Fountain House and Use of Healthcare Resources Zachary Grinspan, MD MS Department of Healthcare Policy and Research Weill Cornell Medical College, New York, NY June 1, 2015 Fountain
Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012
Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012 Types of Care Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate
Manitoba EMR Data Extract Specifications
MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy
Risk Factors of chronic complex co-morbidities Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Statement 1 In real world practice (and in clinical trials), complex co-morbidities are the
King County EMS Stroke Quality Improvement Program
King County EMS Stroke Quality Improvement Program A Report from the King County EMS Medical QI Section March 2012 Prepared by Sofia Husain, Jim Duren, and Norm Nedell OBJECTIVE The goal of the King County
